Literature DB >> 1705008

Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins.

J R McWhirter1, J Y Wang.   

Abstract

Chronic myelogenous leukemia and one type of acute lymphoblastic leukemia are characterized by a 9;22 chronosome translocation in which 5' sequences of the bcr gene become fused to the c-abl proto-oncogene. The resulting chimeric genes encode bcr/abl fusion proteins which have deregulated tyrosine kinase activity and appear to play an important role in induction of these leukemias. A series of bcr/abl genes were constructed in which nested deletions of the bcr gene were fused to the c-abl gene. The fusion proteins encoded by these genes were assayed for autophosphorylation in vivo and for differences in subcellular localization. Our results demonstrate that bcr sequences activate two functions of c-abl; the tyrosine kinase activity and a previously undescribed microfilament-binding function. Two regions of bcr which activate these functions to different degrees have been mapped: amino acids 1 to 63 were strongly activating and amino acids 64 to 509 were weakly activating. The tyrosine kinase and microfilament-binding functions were not interdependent, as a kinase defective bcr/abl mutant still associated with actin filaments and a bcr/abl mutant lacking actin association still had deregulated kinase activity. Modification of actin filament functions by the bcr/abl tyrosine kinase may be an important event in leukemogenesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1705008      PMCID: PMC369443          DOI: 10.1128/mcb.11.3.1553-1565.1991

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  54 in total

1.  Isolation of antibodies for phosphotyrosine by immunization with a v-abl oncogene-encoded protein.

Authors:  J Y Wang
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

2.  Similarity in membrane proteins.

Authors:  A R Rodaway; M J Sternberg; D L Bentley
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

3.  Reduction in protein tyrosine phosphorylation during differentiation of human leukemia cell line K-562.

Authors:  J M Richardson; A O Morla; J Y Wang
Journal:  Cancer Res       Date:  1987-08-01       Impact factor: 12.701

4.  The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc.

Authors:  T G Lugo; O N Witte
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

5.  Selective transformation of primitive lymphoid cells by the BCR/ABL oncogene expressed in long-term lymphoid or myeloid cultures.

Authors:  J C Young; O N Witte
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

6.  Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells.

Authors:  J McLaughlin; E Chianese; O N Witte
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

7.  Nucleotide sequence analysis of human abl and bcr-abl cDNAs.

Authors:  E Fainstein; M Einat; E Gokkel; C Marcelle; C M Croce; R P Gale; E Canaani
Journal:  Oncogene       Date:  1989-12       Impact factor: 9.867

8.  Phosphotyrosine antibodies identify the p210c-abl tyrosine kinase and proteins phosphorylated on tyrosine in human chronic myelogenous leukemia cells.

Authors:  L Naldini; A Stacchini; D M Cirillo; M Aglietta; F Gavosto; P M Comoglio
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

9.  N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl.

Authors:  P Jackson; D Baltimore
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

10.  Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential.

Authors:  W M Franz; P Berger; J Y Wang
Journal:  EMBO J       Date:  1989-01       Impact factor: 11.598

View more
  62 in total

1.  BCR/ABL inhibition by an escort/phosphatase fusion protein.

Authors:  Y M Lim; S Wong; G Lau; O N Witte; J Colicelli
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

2.  Identifying transient protein-protein interactions in EphB2 signaling by blue native PAGE and mass spectrometry.

Authors:  Costel C Darie; Katrin Deinhardt; Guoan Zhang; Helene S Cardasis; Moses V Chao; Thomas A Neubert
Journal:  Proteomics       Date:  2011-10-28       Impact factor: 3.984

Review 3.  Treatment for chronic myelogenous leukemia: the long road to imatinib.

Authors:  Tony Hunter
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

4.  Cytoplasmic SnoN in normal tissues and nonmalignant cells antagonizes TGF-beta signaling by sequestration of the Smad proteins.

Authors:  Ariel R Krakowski; Julien Laboureau; Alain Mauviel; Mina J Bissell; Kunxin Luo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-18       Impact factor: 11.205

5.  A chimeric receptor/oncogene that can be regulated by a ligand in vitro and in vivo.

Authors:  K Okuda; A D'Andrea; R A Etten; J D Griffin
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

6.  BCR/ABL induces multiple abnormalities of cytoskeletal function.

Authors:  R Salgia; J L Li; D S Ewaniuk; W Pear; E Pisick; S A Burky; T Ernst; M Sattler; L B Chen; J D Griffin
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

7.  Transcriptional activation of a ras-like gene (kir) by oncogenic tyrosine kinases.

Authors:  L Cohen; R Mohr; Y Y Chen; M Huang; R Kato; D Dorin; F Tamanoi; A Goga; D Afar; N Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

8.  Identification of nuclear export inhibitors with potent anticancer activity in vivo.

Authors:  Sarah C Mutka; Wen Qing Yang; Steven D Dong; Shannon L Ward; Darren A Craig; Pieter B M W M Timmermans; Sumati Murli
Journal:  Cancer Res       Date:  2009-01-15       Impact factor: 12.701

9.  Nonmyristoylated Abl proteins transform a factor-dependent hematopoietic cell line.

Authors:  G Q Daley; R A Van Etten; P K Jackson; A Bernards; D Baltimore
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

10.  A 41-kilodalton protein is a potential substrate for the p210bcr-abl protein-tyrosine kinase in chronic myelogenous leukemia cells.

Authors:  E Freed; T Hunter
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.